Snímek obrazovky 2024-11-18 175122 zmenšené
Banner-HP-1920x750-technologie-v2-EN
Onemocnění-PC-EN
Banner-mobil-1080x1920x-technologie-EN
Onemocnění-Mobil_EN

Why is Unique unique?

As the name suggests, our company is UNIQUE mainly thanks to the products it has developed itself.

Liposomal NANO formulations are the clear choice in today’s medicinal cannabis market for anyone who requires accurate dosing, consistency, quick effectiveness and high bioavailability from the product.

The fact that our NANO formulations are always under 50 nm in size, and with a Zeta – 5 to – 10 MV, stability makes this product one-of-a-kind in this category on the current market.

The smallest size of NANO liposomes on the market

For the production of liposomal NANO formulations, particle size is always the main goal and therefore the controlling factor.

We use the Malvern ZETASIZER Nano -ZS for such measurements.

This device is the only one on the world market that can accurately measure particles from units of nanometers. In order for the measurement to be as accurate as possible, we set 10 measurements for each measurement, which contains another 10 measurements, i.e. the resulting particle size is the average of 100 x particle size measurements.

Read more
Read more Documents to download

Zeta factor

The second important factor in the production of liposomal carriers is the stability of the solution, or “ZETA FACTOR”.

Its importance is crucial in manufacturing, without the strong electrical charge between individual particles, the particles would stick together and the liposomal formulation would disintegrate.

This measurement is carried out again already on the mentioned Malvern device. An electric charge in the range of -4 to -10 MV ensures the stability of the solution for a period of 48 months, when stored in a cold and dark place.

Materials for download

We are an approved supplier of medical cannabis products. Our company is purely Czech and is based in Ústí nad Labem. We focus on the Czech and international market.

We cooperate intensively with universities, pharmaceutical companies and state medical institutions.

We use nanoliposomal technology to produce our products with high bioavailability and speed of action. This sets our products apart from most commercially available cannabis products.

We organise educational events (online and live) on the effects of cannabis for professionals and the general public.

The composition of our products is inspired by evidence-based medicine.

We were the first in the world to offer cannabis products in liposomal form. We are an approved importer of medicines by the Anvisa institution for Brazil (equivalent to the State Drug Control Office).

Nanoliposomání produkty Unique Therapeutics jsem doporučil svým pacientům s Alzheimerem, RS, Parkinsonem a chronickými bolestivými syndromy.

MUDr. Evžen Nešpor,
MUDr. Evžen Nešpor,praxe 40 let se zaměřením na neurologii a kontrolu bolesti
(Praha, POLIKLINIKA I. P. Pavlova (neurologie).

U všech klientů došlo ke zlepšení stavu či stabilizaci onemocnění a nebyly pozorovány žádné nepříznivé vedlejší účinky a hodlají dále pokračovat v užívání produktů firmy Unique Therapeutics

MUDr. Karel Pýcha
MUDr. Karel Pýchadětský chirurg, Praha

S produkty Unique mám zkušenosti a vím, že si tyto produkty pochvaluji jak sportovci z důvodů rychlejší regenerace, tak i lidé hledající úlevu od různých typů bolesti
Jako farmaceut si dovolím připomenout, aby konzumenti jakýchkoliv doplňků stravy vždy ve svém zájmu informovali o této skutečnosti jak lékaře tak i nás farmaceuty.

PharmDr. Veronika Prokešová, LL.M.
PharmDr. Veronika Prokešová, LL.M.obor klinická farmacie
Previous
Next

Based on scientific
evidence

Our products are based on Evidence-Based Medicine (also known as EBM), which is the use of scientifically validated evidence that a physician evaluates as the appropriate way to care for patients. EBM uses current information that has not yet been anchored in traditional medicine. It is thus a treatment that uses innovative yet proven effective approaches.

Blog

Our Laboratories

The development and production of hemp products is concentrated in a modern production complex in Ústí nad Labem, where the company's headquarters are located. We work with state-of-the-art equipment with an emphasis on the quality and efficiency of the final products.

We treat with cannabis
over 10 years

Together with our partners, we have created over 30 brands of cannabis products on the market. We have launched more than 2,150,000 daily doses on the Czech market.

Our Bisaliv product line (distributed in Brazil) is the only one based on nanoliposomal technology in cannabis treatment. This technology enables the best results and action of therapeutic products with high bioavailability and speed of action.

0
Flight we treat with cannabis
0
Dosage contains 1 litre of Hemp Nano liposome
0
Daily doses we have already launched
IV intravenous administration (in research phase) 0
Liposomal Nano Cannabinoids 0
Inhalation using Vape Pens and approved inhalers (approx.) 0
Smoking the Cannabis flower 0
Hemp oils, pills, gelatin candies (approx.) 0

Source: lyphe.com/bioavailability-and-cannabis

Our Team

Radek Hlaváček

One of the founding members of Unique Therapeutics, a Canadian company based in Ústí nad Labem, the city where Radek lived until he was 19 years old. As an immigrant he moved to Switzerland and later to Canada, where he has lived with his wife since 1991. He started cultivating cannabis and using the flowers and extracts of Cannabis for medical purposes in 2000 after obtaining his MMAR License (Marijuana Medical Access Regulations).

Ivana Bednářová

Ivana Bednářová has twenty years of experience in sales, marketing and public relations, having held senior positions in a number of international companies during her career. Within her own marketing and PR agency, she founded and led several successful projects related to healthy lifestyle and international certification of food supplements and food. A graduate of Anglo American University with a degree in Economics, she has three children and her hobbies include sports, travel and gastronomy.

Liam Duff

As the Chief Science and Technology Officer at Unique Therapeutics, Liam is responsible for the development, testing, manufacturing and compliance of our manufacturing processes as well as day-to-day operations. Intellectual property and technology are at the core of our company Unique Therapeutics and Liam is responsible for ensuring we are always at the forefront of the most effective ways to deliver cannabinoids into the body and ensuring our quality is the best it can be.

Ranjit S. Bhardwaj

Ranjit S. Bhardwaj after studying biomedical sciences in immunology, cancer immunobiology and regenerative medicine has specialized and qualified in cancer immunobiology and regenerative medicine, cellular and molecular pathology. Dr. Ranjit Bhardwaj is active in a network of cannabis physicians and prescribers, is involved in clinical research projects at universities and R&D forums in Germany and abroad, and holds corporate advisory roles in the medical and pharmaceutical industry.

Jakub Kryšpín

Jakub Kryšpín is an expert in cannabis treatment. Since 2013 he has been successfully treating with the help of Phoenix Tears. Since 2021, he has continued his work in healing and scientific knowledge in cooperation with our company, focusing primarily on the treatment of oncological, but also neurodegenerative, autoimmune diseases and other diseases that somehow affect the human endocannabinoid system. Jakub has been suffering from multiple sclerosis since 2006 and was once in a wheelchair. He claims that cannabis is the most important herb on planet Earth, given its wide range of uses.

Ing. Miloš Podolský

Miloš Podolský became a new member of the Unique Therapeutics Global team in 2024. Miloš's experience in international sales and marketing has become a welcome asset not only for the company. Unique, but also for our international partners. Unique Therapeutics Global has its roots and experience in Canada where the founding members of Unique have been involved since 2012 in the development of cannabis legalization legislation and conditions for cultivation and processing of medical cannabis. This experience and knowledge helps us to establish cooperation with foreign partners who are thinking about legalization and medical cannabis in their country or are only in the beginning. By combining the many years of knowledge of our company and the business experience of Milos Podolski, we are able to offer a wide range of options both in terms of legislation and production. This places Unique Therapeutics Global with its SEED TO SALE program among the world leaders in the cannabis industry. Milos' hobbies include sailing, boating, sports car racing and traveling.

John Wanyu

Current research on CBD shows that cannabis could help African nations with the disease sickle cell anemia. Meetings held with Ugandan government officials in October 2024 have provided the impetus and foundation for the preparation of clinical trials to test the efficacy of Unique Therapeutics' liposomal formulations in the treatment of Sickle Cell Disease. Johnny will be our coordinator and representative in Uganda. His role is to prepare the conditions for the clinical trial, conduct the clinical trial in collaboration with the collaborating university hospital and the Ministry of Health. We hope that our data will confirm the efficacy of Unique T products in the treatment, Unique T will ensure the production and distribution of the drug product in Uganda.